Assessment of acute functional effects of perfluorooctanoic acid (PFOA), heptafluorobutyric acid (HFBA), and hexafluoropropylene oxide dimer acid (HFPO-DA) in human iPSC-derived cardiomyocytes using multielectrode arrays
Min Woo Kim, Myeonghee Lee, Jeong Hwan Park, Seul-Gi Lee, Jeong-Seop Oh, Shinhye Park, Youngin Jeong, Yoonseo Kim, Hyewon Shin, C-Yoon Kim, Hyung Min Chung
{"title":"Assessment of acute functional effects of perfluorooctanoic acid (PFOA), heptafluorobutyric acid (HFBA), and hexafluoropropylene oxide dimer acid (HFPO-DA) in human iPSC-derived cardiomyocytes using multielectrode arrays","authors":"Min Woo Kim, Myeonghee Lee, Jeong Hwan Park, Seul-Gi Lee, Jeong-Seop Oh, Shinhye Park, Youngin Jeong, Yoonseo Kim, Hyewon Shin, C-Yoon Kim, Hyung Min Chung","doi":"10.1016/j.etap.2026.105184","DOIUrl":null,"url":null,"abstract":"<div><div>Per- and polyfluoroalkyl substances (PFASs) are persistent environmental pollutants associated with public health risks. The cardiac electrophysiological effects of the representative long-chain PFAS perfluorooctanoic acid (PFOA) and short-chain PFASs such as heptafluorobutyric acid (HFBA) and hexafluoropropylene oxide dimer acid (HFPO-DA) remain insufficiently understood. In this study, the electrophysiological effects of PFASs were evaluated in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) using multielectrode array (MEA) analysis. Exposure to 100 μM PFOA increased beat period and field potential duration, while reducing spike amplitude in a concentration-dependent manner without affecting contractility. In contrast, HFBA and HFPO-DA did not cause notable changes in either electrophysiological or contractility parameters. These results suggest that acute PFOA exposure disrupts cardiac electrophysiological function, whereas HFBA and HFPO-DA showed no notable effects within the tested conditions.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"127 ","pages":"Article 105184"},"PeriodicalIF":4.6000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668926002620","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Per- and polyfluoroalkyl substances (PFASs) are persistent environmental pollutants associated with public health risks. The cardiac electrophysiological effects of the representative long-chain PFAS perfluorooctanoic acid (PFOA) and short-chain PFASs such as heptafluorobutyric acid (HFBA) and hexafluoropropylene oxide dimer acid (HFPO-DA) remain insufficiently understood. In this study, the electrophysiological effects of PFASs were evaluated in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) using multielectrode array (MEA) analysis. Exposure to 100 μM PFOA increased beat period and field potential duration, while reducing spike amplitude in a concentration-dependent manner without affecting contractility. In contrast, HFBA and HFPO-DA did not cause notable changes in either electrophysiological or contractility parameters. These results suggest that acute PFOA exposure disrupts cardiac electrophysiological function, whereas HFBA and HFPO-DA showed no notable effects within the tested conditions.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.